Ganga Pharmaceuticals Limited (BOM:539680)
India
· Delayed Price · Currency is INR 12.00
0.00 (0.00%)
At close: Feb 12, 2026
Ganga Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | 0.8 | 0.79 | 0.47 | 0.39 | 0.38 | 0.2 | Upgrade
|
| Depreciation & Amortization | 0.48 | 0.47 | 0.49 | 0.56 | 0.55 | 0.54 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -1.88 | - | - | - | - | Upgrade
|
| Other Operating Activities | -1.48 | -0.78 | -0.59 | -1.14 | -0.69 | -0.66 | Upgrade
|
| Change in Accounts Receivable | -0.45 | 0.13 | -0.34 | 0.03 | -0.72 | 2.51 | Upgrade
|
| Change in Inventory | 0.13 | 0.59 | -0.59 | -0.33 | -0.17 | -0.93 | Upgrade
|
| Change in Accounts Payable | -0.45 | 1.78 | -4.81 | 0.55 | 0.85 | -1.16 | Upgrade
|
| Change in Other Net Operating Assets | -7.05 | -6.86 | -7.28 | -0.47 | -2.31 | -2.25 | Upgrade
|
| Operating Cash Flow | -8.03 | -5.77 | -12.64 | -0.4 | -2.11 | -1.75 | Upgrade
|
| Capital Expenditures | -1.08 | -0.99 | -0.22 | -0.15 | -0.15 | -0.17 | Upgrade
|
| Investment in Securities | -6.06 | 10.32 | -0.88 | 2.09 | -0.55 | 0.4 | Upgrade
|
| Other Investing Activities | 2.91 | 2.48 | 2.39 | 2.98 | 2.59 | 2.53 | Upgrade
|
| Investing Cash Flow | -4.24 | 11.81 | 1.3 | 4.92 | 1.89 | 2.76 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 2.18 | 0.81 | Upgrade
|
| Long-Term Debt Repaid | - | -1.63 | -2.4 | -2.57 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -2.09 | -1.63 | -2.4 | -2.57 | 2.18 | 0.81 | Upgrade
|
| Issuance of Common Stock | 11.29 | - | 10.85 | - | - | - | Upgrade
|
| Other Financing Activities | -1.46 | -1.69 | 2.9 | -1.87 | -1.9 | -1.79 | Upgrade
|
| Financing Cash Flow | 7.74 | -3.32 | 11.35 | -4.44 | 0.27 | -0.98 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | -0 | -0 | 0 | - | - | Upgrade
|
| Net Cash Flow | -4.53 | 2.73 | 0.01 | 0.09 | 0.06 | 0.03 | Upgrade
|
| Free Cash Flow | -9.12 | -6.76 | -12.86 | -0.55 | -2.25 | -1.92 | Upgrade
|
| Free Cash Flow Margin | -33.85% | -25.63% | -47.02% | -2.11% | -9.06% | -8.10% | Upgrade
|
| Free Cash Flow Per Share | -1.25 | -1.02 | -1.95 | -0.14 | -0.56 | -0.47 | Upgrade
|
| Cash Interest Paid | 1.46 | 1.69 | 1.81 | 1.87 | 1.9 | 1.79 | Upgrade
|
| Cash Income Tax Paid | - | 0.15 | 0.17 | 0.16 | 0.14 | 0.09 | Upgrade
|
| Levered Free Cash Flow | -11.83 | -9.22 | -11.54 | -2.85 | -3.05 | -4.61 | Upgrade
|
| Unlevered Free Cash Flow | -10.92 | -8.16 | -10.41 | -1.68 | -1.86 | -3.25 | Upgrade
|
| Change in Working Capital | -7.83 | -4.36 | -13.01 | -0.22 | -2.35 | -1.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.